A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 266
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : EAN
Long Form : experimental autoimmune neuritis
No. Year Title Co-occurring Abbreviation
2021 Ginsenoside Rd attenuates mouse experimental autoimmune neuritis by modulating monocyte subsets conversion. GBS
2021 Nuclear factor kappa B inhibitor suppresses experimental autoimmune neuritis in mice via declining macrophages polarization to M1 type. GBS, NF, PNS
2021 The therapeutic effects of ginkgolides in Guillain-Barré syndrome and experimental autoimmune neuritis. GBS, IFN, IL, P0 peptide, Th
2020 Autoantigen specific IL-2 activated CD4+CD25+T regulatory cells inhibit induction of experimental autoimmune neuritis. PNM
2020 Axonal degeneration in Guillain-Barré syndrome: a reappraisal. GBS
2020 Effects of microRNA-338 Transfection into Sciatic Nerve on Rats with Experimental Autoimmune Neuritis. IVIG, miR-338-LV
2020 Immunomodulatory and anti-oxidative effect of the direct TRPV1 receptor agonist capsaicin on Schwann cells. CIDP, DRG, MHC-II, SCs
2020 Inflammatory oedema of nerve trunks may be pathogenic in very early Guillain-Barré syndrome. EFP
2020 M1 Macrophage Derived Exosomes Aggravate Experimental Autoimmune Neuritis via Modulating Th1 Response. EVs, GBS
10  2020 Ultrastructural characterization of mitochondrial damage in experimental autoimmune neuritis. ---
11  2019 Autoimmunity and cytokines in Guillain-Barre syndrome revisited: review of pathomechanisms with an eye on therapeutic options. GBS, LOS
12  2019 Blocking Thrombin Significantly Ameliorates Experimental Autoimmune Neuritis. CFA, GBS, PAR1, TLCK
13  2019 Effect of fasudil on experimental autoimmune neuritis and its mechanisms of action. IFN-gamma, IL, iNOS, MBP
14  2019 Effects of APELIN-13 on the expression of IL-6, TNF-alpha, and IFN-gamma in rats with experimental autoimmune neuritis. ELISA, IFN-gamma, IL-6, PCR, TNF-alpha
15  2019 FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis. c-EAN, CIDP, S1P
16  2019 Induction of Regulatory Properties in the Intestinal Immune System by Dimethyl Fumarate in Lewis Rat Experimental Autoimmune Neuritis. DMF, GALT, HO-1, TLR4
17  2019 Natural Diterpenoid Oridonin Ameliorates Experimental Autoimmune Neuritis by Promoting Anti-inflammatory Macrophages Through Blocking Notch Pathway. GBS
18  2019 Th17 cells and their cytokines serve as potential therapeutic target in experimental autoimmune neuritis. GBS, RORgammat
19  2019 Time Course of Axon and Myelin Degeneration in Peripheral Nerves in Experimental Autoimmune Neuritis Rats. GBS
20  2019 Transcriptomes in rat sciatic nerves at different stages of experimental autoimmune neuritis determined by RNA sequencing. GBS
21  2018 Beneficial or Harmful Role of Macrophages in Guillain-Barre Syndrome and Experimental Autoimmune Neuritis. GBS, PNS
22  2018 Capsaicin-enriched diet ameliorates autoimmune neuritis in rats. ---
23  2018 Class I PI3K inhibitor ZSTK474 attenuates experimental autoimmune neuritis by decreasing the frequency of Th1/Th17 cells and reducing the production of proinflammatory cytokines. GBS, IL
24  2018 Enhanced glycolysis contributes to the pathogenesis of experimental autoimmune neuritis. 2-DG, DC, GBS
25  2018 Mitochondrial damage and "plugging" of transport selectively in myelinated, small-diameter axons are major early events in peripheral neuroinflammation. GBS
26  2018 Myelin Protein Zero180-199 Peptide Induced Experimental Autoimmune Neuritis in C57BL/6 Mice. ---
27  2018 Roles of macrophage migration inhibitory factor in Guillain-Barre syndrome and experimental autoimmune neuritis: beneficial or harmful? GBS, MIF, NCBI
28  2018 The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain-Barre syndrome. FOXP3, IFN-alpha, VIP
29  2018 Therapeutic Effect of CD4+CD25+ Regulatory T Cells Amplified In Vitro on Experimental Autoimmune Neuritis in Rats. GBS, IL-2, TGF-beta
30  2018 Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis. AT-EAN, GFP, PNS
31  2018 Treatment of Guillain-Barre syndrome with Bifidobacterium infantis through regulation of T helper cells subsets. GBS, HC, PCR, Th
32  2017 4-Aminopyridine ameliorates experimental autoimmune neuritis in Lewis rats. 4-AP
33  2017 A Brain-Derived Neurotrophic Factor-Based p75NTR Peptide Mimetic Ameliorates Experimental Autoimmune Neuritis Induced Axonal Pathology and Demyelination. p75NTR, PNS
34  2017 A Functional and Neuropathological Testing Paradigm Reveals New Disability-Based Parameters and Histological Features for P0180-190-Induced Experimental Autoimmune Neuritis in C57BL/6 Mice. ---
35  2017 A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments. PNS
36  2017 Inhibition of triggering receptor expressed on myeloid cells-1 ameliorates experimental autoimmune neuritis. LP17
37  2017 Parthenolide inhibits the initiation of experimental autoimmune neuritis. PAR
38  2017 PR-957, a selective inhibitor of immunoproteasome subunit low-MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing Th17-cell differentiation and regulating cytokine production. STAT3, Th
39  2017 Tissue resident macrophages are sufficient for demyelination during peripheral nerve myelin induced experimental autoimmune neuritis? PNM
40  2016 Attenuation of experimental autoimmune neuritis with locally administered lovastatin-encapsulating poly(lactic-co-glycolic) acid nanoparticles. AIDP, GBS, PLGA
41  2016 Autophagy is involved in the pathogenesis of experimental autoimmune neuritis in rats. LC3
42  2016 Bowman-Birk inhibitor concentrate suppresses experimental autoimmune neuritis via shifting macrophages from M1 to M2 subtype. BBIC, GBS, P0 peptide, PNS
43  2016 Chronic inflammatory demyelinating polyradiculoneuropathy: A new animal model for new therapeutic targets. CIDP, GBS
44  2016 Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages. DMF, GBS, HO-1, mRNA, Nrf2
45  2016 Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats. PD-1, PD-L1
46  2016 RAD001 (everolimus) attenuates experimental autoimmune neuritis by inhibiting the mTOR pathway, elevating Akt activity and polarizing M2 macrophages. GBS, mTOR
47  2016 Resolvin D1 Programs Inflammation Resolution by Increasing TGF-beta Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis. AIDP, PNS, RvD1, TGF-beta, Treg
48  2016 Traditional Chinese medicine Yisui Tongjing relieved neural severity in experimental autoimmune neuritis rat model. MNCV, YSTJ
49  2016 Tumor necrosis factor-alpha in Guillain-Barre syndrome, friend or foe? GBS, PNS
50  2015 Administration of SB203580, a p38 MAPK Inhibitor, Reduced the Expression of MMP9, and Relieved Neurologic Severity in the Experimental Autoimmune Neuritis (EAN) in Rats. MAP kinases, MMP-9, p38 MAPK
51  2015 Are Th17 cells and their cytokines a therapeutic target in Guillain-Barre syndrome? GBS, PNS, RORgammaT, Th
52  2015 Forced Exercise Preconditioning Attenuates Experimental Autoimmune Neuritis by Altering Th1 Lymphocyte Composition and Egress. ---
53  2015 Lesional accumulation of CD8(+) cells in sciatic nerves of experimental autoimmune neuritis rats. ---
54  2015 Myelin ultrastructure of sciatic nerve in rat experimental autoimmune neuritis model and its correlation with associated protein expression. ---
55  2015 Suppressive oligodeoxynucleotides induced tolerogenic plasmacytoid dendritic cells and ameliorated the experimental autoimmune neuritis. IDO, pDCs, sODN, TLR
56  2014 Can IFN-gamma be a therapeutic target in Guillain-Barre syndrome? GBS, Th
57  2014 Chrysin attenuates experimental autoimmune neuritis by suppressing immuno-inflammatory responses. GBS
58  2014 Costimulatory molecule CD40 is essential for myelin protein 0 peptide 106-125-induced experimental autoimmune neuritis in mice. ---
59  2014 Curcumin ameliorates rat experimental autoimmune neuritis. IFN, IL
60  2014 Erythropoietin-derived nonerythropoietic peptide ameliorates experimental autoimmune neuritis by inflammation suppression and tissue protection. EPO
61  2014 FoxP3+ regulatory T cells determine disease severity in rodent models of inflammatory neuropathies. FOXP3
62  2014 IL-10, IL-4, and STAT6 promote an M2 milieu required for termination of P0(106-125)-induced murine experimental autoimmune neuritis. Th2
63  2014 Laquinimod exerts strong clinical and immunomodulatory effects in Lewis rat experimental autoimmune neuritis. ---
64  2014 Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis. CE, MNCs, Th, Treg
65  2014 Therapeutic potential of atorvastatin-modified dendritic cells in experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells and NKR-P1(+) cells. statin-DCs
66  2013 Accumulation of fascin+ cells during experimental autoimmune neuritis. ---
67  2013 Beneficial effect of a multimerized immunoglobulin Fc in an animal model of inflammatory neuropathy (experimental autoimmune neuritis). CMAP, IVIG, MCV
68  2013 Berberine ameliorates experimental autoimmune neuritis by suppressing both cellular and humoral immunity. BBR
69  2013 Chemokine-dependent signaling pathways in the peripheral nervous system. BNB
70  2013 Differential effects of CXCR4-CXCL12- and CXCR7-CXCL12-mediated immune reactions on murine P0106-125 -induced experimental autoimmune neuritis. ---
71  2013 Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis. EAE, EPO
72  2013 Erythropoietin is a hypoxia inducible factor-induced protective molecule in experimental autoimmune neuritis. EPO, EPOR, HIF-1alpha
73  2013 Glatiramer acetate ameliorates experimental autoimmune neuritis. CNS, GA, GBS, MBP
74  2013 Keratan sulfate expression in microglia is diminished in the spinal cord in experimental autoimmune neuritis. IFN, IL, KS, TNF
75  2013 Mechanism of experimental autoimmune neuritis in Lewis rats: the dual role of macrophages. GBS
76  2013 Neuropathic pain in animal models of nervous system autoimmune diseases. EAE, GBS, MS
77  2013 New strategies in the management of Guillain-Barré syndrome. GBS
78  2013 Th1/Th2/Th17/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis. GBS, PNS, Th
79  2013 The role of chemokines in Guillain-Barré syndrome. GBS
80  2013 Transplantation of Schwann cells co-cultured with brain-derived neurotrophic factor for the treatment of experimental autoimmune neuritis. BDNF, SCs
81  2013 Treatment for experimental autoimmune neuritis with clodronate (Bonefos). GBS
82  2012 Attenuated EAN in TNF-α deficient mice is associated with an altered balance of M1/M2 macrophages. IFN, IL, KO, NO, TNF, TNFR, WT
83  2012 Forced-exercise attenuates experimental autoimmune neuritis. CMAP, MNCV
84  2012 IFN-gamma deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response. CE, IFN-gamma, IL, KO, MHC, WT
85  2012 Lesional infiltration of receptor activator of nuclear factor-κB ligand⁺ cells in experimental autoimmune neuritis rats. RANKL
86  2012 Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation. EAE
87  2012 Pioglitazone, PPARγ agonist, attenuates experimental autoimmune neuritis. PPARgamma
88  2011 APOE epsilon3 attenuates experimental autoimmune neuritis by modulating T cell, macrophage and Schwann cell functions. APOE, PNS, SC, TG, WT
89  2011 Apolipoprotein E isoform-specific effects on cytokine and nitric oxide production from mouse Schwann cells after inflammatory stimulation. APOE, GBS, IFN, IL, LPS, NF, NO, PNS, SCs, Tg, WT
90  2011 Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells. GBS, MNC
91  2011 CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology. AMAN, CIDP, GBS, MMN
92  2011 Differential susceptibility to experimental autoimmune neuritis in Lewis rat strains is associated with T-cell immunity to myelin antigens. GBS, PNS
93  2011 Distinct expression of Tim-3 during different stages of rat experimental autoimmune neuritis. ---
94  2011 Doxycycline attenuates peripheral inflammation in rat experimental autoimmune neuritis. ---
95  2011 Erythropoietin ameliorates rat experimental autoimmune neuritis by inducing transforming growth factor-β in macrophages. EPO, GBS, PNS, TGF
96  2011 Inactivation of TLR9 by a suppressive oligodeoxynucleotides can ameliorate the clinical signs of EAN. nODN, ODN, sODN, TLRs
97  2011 Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis. PBS
98  2011 Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules. ---
99  2011 The strategies used for treatment of experimental autoimmune neuritis (EAN): a beneficial effect of glatiramer acetate administered intraperitoneally. ANOVA, EAE, GA, GBS
100  2010 Dual role of B cells with accelerated onset but reduced disease activity in P0₁₀₆₋₁₂₅-induced experimental autoimmune neuritis of IgH ⁰(/)⁰ mice. IFN, p.i